Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.745
+0.005 (0.18%)
At close: Apr 28, 2026, 4:00 PM EDT
2.730
-0.015 (-0.55%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $66.03 million as of April 28, 2026. Its market cap has decreased by -12.79% in one year.
Market Cap
66.03M
Enterprise Value
61.11M
1-Year Change
-12.79%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $66.03M, an increase of 4.63%. That is a compound annual growth rate of 0.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prenetics Global | 308.47M |
| Burning Rock Biotech | 222.76M |
| FONAR | 123.44M |
| Insight Molecular Diagnostics | 120.95M |
| Biodesix | 107.54M |
| MDxHealth | 106.84M |
| Precipio | 49.93M |
| Check-Cap | 11.15M |